[HTML][HTML] Monocytes and Macrophages in COVID-19
COVID-19 is a contagious viral disease caused by SARS-CoV-2 that led to an ongoing
pandemic with massive global health and socioeconomic consequences. The disease is …
pandemic with massive global health and socioeconomic consequences. The disease is …
Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19)
Y Zhou, J Chi, W Lv, Y Wang - Diabetes/metabolism research …, 2021 - Wiley Online Library
The outbreak of the coronavirus disease 2019 (Covid‐19) has become an evolving
worldwide health crisis. With the rising prevalence of obesity and diabetes has come an …
worldwide health crisis. With the rising prevalence of obesity and diabetes has come an …
[HTML][HTML] Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19
A Silvin, N Chapuis, G Dunsmore, AG Goubet… - Cell, 2020 - cell.com
Blood myeloid cells are known to be dysregulated in coronavirus disease 2019 (COVID-19),
caused by SARS-CoV-2. It is unknown whether the innate myeloid response differs with …
caused by SARS-CoV-2. It is unknown whether the innate myeloid response differs with …
[HTML][HTML] Nutrition, immunity and COVID-19
PC Calder - BMJ nutrition, prevention & health, 2020 - ncbi.nlm.nih.gov
The immune system protects the host from pathogenic organisms (bacteria, viruses, fungi,
parasites). To deal with this array of threats, the immune system has evolved to include a …
parasites). To deal with this array of threats, the immune system has evolved to include a …
[PDF][PDF] Corona virus: a review of COVID-19
Corona virus causes respiratory infection including pneumonia, cold, sneezing and
coughing while in animal it causes diarrhea and upper respiratory diseases. Corona virus …
coughing while in animal it causes diarrhea and upper respiratory diseases. Corona virus …
[HTML][HTML] A new threat from an old enemy: Re‑emergence of coronavirus
AO Docea, A Tsatsakis… - International …, 2020 - spandidos-publications.com
The new outbreak of coronavirus from December 2019 has brought attention to an old viral
enemy and has raised concerns as to the ability of current protection measures and the …
enemy and has raised concerns as to the ability of current protection measures and the …
[HTML][HTML] Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
SB Solerte, A Di Sabatino, M Galli, P Fiorina - Acta diabetologica, 2020 - Springer
Aims SARS–CoV-2 causes severe respiratory syndrome (COVID-19) with high mortality due
to a direct cytotoxic viral effect and a severe systemic inflammation. We are herein …
to a direct cytotoxic viral effect and a severe systemic inflammation. We are herein …
[HTML][HTML] Covid-19: perspectives on innate immune evasion
The ongoing outbreak of Coronavirus disease 2019 infection achieved pandemic status on
March 11, 2020. As of September 8, 2020 it has caused over 890,000 mortalities world-wide …
March 11, 2020. As of September 8, 2020 it has caused over 890,000 mortalities world-wide …
Middle East respiratory syndrome coronavirus (MERS‐CoV): infection, immunological response, and vaccine development
A Mubarak, W Alturaiki… - Journal of immunology …, 2019 - Wiley Online Library
Middle East respiratory syndrome coronavirus (MERS‐CoV) first emerged in late 2012.
Since its emergence, a total of 2279 patients from 27 countries have been infected across …
Since its emergence, a total of 2279 patients from 27 countries have been infected across …
[HTML][HTML] Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 infection
Y Liang, ML Wang, CS Chien, AA Yarmishyn… - Frontiers in …, 2020 - frontiersin.org
A sudden outbreak of COVID-19 caused by a novel coronavirus, SARS-CoV-2, in Wuhan,
China in December 2019 quickly grew into a global pandemic, putting at risk not only the …
China in December 2019 quickly grew into a global pandemic, putting at risk not only the …